PMID- 35236727 OWN - NLM STAT- MEDLINE DCOM- 20221010 LR - 20221207 IS - 1399-3003 (Electronic) IS - 0903-1936 (Print) IS - 0903-1936 (Linking) VI - 60 IP - 4 DP - 2022 Oct TI - Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. LID - 10.1183/13993003.03101-2021 [doi] LID - 2103101 AB - BACKGROUND: Many people recovering from coronavirus disease 2019 (COVID-19) experience prolonged symptoms, particularly breathlessness. We urgently need to identify safe and effective COVID-19 rehabilitative strategies. The aim of the current study was to investigate the potential rehabilitative role of inspiratory muscle training (IMT). METHODS: 281 adults (age 46.6+/-12.2 years; 88% female) recovering from self-reported COVID-19 (9.0+/-4.2 months post-acute infection) were randomised 4:1 to an 8-week IMT or a "usual care" waitlist control arm. Health-related quality-of-life and breathlessness questionnaires (King's Brief Interstitial Lung Disease (K-BILD) and Transition Dyspnoea Index (TDI)), respiratory muscle strength, and fitness (Chester Step Test) were assessed pre- and post-intervention. The primary end-point was K-BILD total score, with the K-BILD domains and TDI being key secondary outcomes. RESULTS: According to intention to treat, there was no difference between groups in K-BILD total score post-intervention (control: 59.5+/-12.4; IMT: 58.2+/-12.3; p<0.05) but IMT elicited clinically meaningful improvements in the K-BILD domains for breathlessness (control: 59.8+/-12.6; IMT: 62.2+/-16.2; p<0.05) and chest symptoms (control: 59.2+/-18.7; IMT: 64.5+/-18.2; p<0.05), along with clinically meaningful improvements in breathlessness according to TDI (control: 0.9+/-1.7 versus 2.0+/-2.0; p<0.05). IMT also improved respiratory muscle strength and estimated aerobic fitness. CONCLUSIONS: IMT may represent an important home-based rehabilitation strategy for wider implementation as part of COVID-19 rehabilitative strategies. Given the diverse nature of long COVID, further research is warranted on the individual responses to rehabilitation; the withdrawal rate herein highlights that no one strategy is likely to be appropriate for all. CI - Copyright (c)The authors 2022. FAU - McNarry, Melitta A AU - McNarry MA AUID- ORCID: 0000-0003-0813-7477 AD - Applied Sports, Technology, Exercise and Medicine Research Centre, Swansea University, Swansea, UK m.mcnarry@swansea.ac.uk. FAU - Berg, Ronan M G AU - Berg RMG AUID- ORCID: 0000-0002-5757-9506 AD - Dept of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen and Centre for Physical Activity Research, Copenhagen, Denmark. AD - Dept of Clinical Physiology and Nuclear Medicine, University Hospital Copenhagen - Rigshospitalet, Copenhagen, Denmark. FAU - Shelley, James AU - Shelley J AD - Applied Sports, Technology, Exercise and Medicine Research Centre, Swansea University, Swansea, UK. FAU - Hudson, Joanne AU - Hudson J AD - Applied Sports, Technology, Exercise and Medicine Research Centre, Swansea University, Swansea, UK. FAU - Saynor, Zoe L AU - Saynor ZL AD - Physical Activity, Health and Rehabilitation Thematic Research Group, School of Sport, Health and Exercise Science, Faculty of Science and Health, University of Portsmouth, Portsmouth, UK. FAU - Duckers, Jamie AU - Duckers J AUID- ORCID: 0000-0003-3004-279X AD - All Wales Adult CF Centre, Cardiff and Vale University Health Board, Cardiff, UK. FAU - Lewis, Keir AU - Lewis K AD - Hywel Dda University Health Board, Carmarthen, UK. AD - School of Medicine, Swansea University, Swansea, UK. FAU - Davies, Gwyneth A AU - Davies GA AD - School of Medicine, Swansea University, Swansea, UK. FAU - Mackintosh, Kelly A AU - Mackintosh KA AD - Applied Sports, Technology, Exercise and Medicine Research Centre, Swansea University, Swansea, UK. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20221006 PL - England TA - Eur Respir J JT - The European respiratory journal JID - 8803460 SB - IM MH - Adult MH - Breathing Exercises MH - *COVID-19/complications MH - Dyspnea/therapy MH - Female MH - Humans MH - *Lung Diseases, Interstitial MH - Male MH - Middle Aged MH - Muscle Strength MH - Quality of Life MH - Respiratory Muscles MH - Post-Acute COVID-19 Syndrome PMC - PMC8900538 COIS- Conflict of interest: The authors have no conflicts of interest to declare. EDAT- 2022/03/04 06:00 MHDA- 2022/10/12 06:00 PMCR- 2022/03/07 CRDT- 2022/03/03 05:32 PHST- 2021/12/06 00:00 [received] PHST- 2022/02/14 00:00 [accepted] PHST- 2022/03/04 06:00 [pubmed] PHST- 2022/10/12 06:00 [medline] PHST- 2022/03/03 05:32 [entrez] PHST- 2022/03/07 00:00 [pmc-release] AID - 13993003.03101-2021 [pii] AID - ERJ-03101-2021 [pii] AID - 10.1183/13993003.03101-2021 [doi] PST - epublish SO - Eur Respir J. 2022 Oct 6;60(4):2103101. doi: 10.1183/13993003.03101-2021. Print 2022 Oct.